NRG ONCOLOGY RTOG 1205: RANDOMIZED PHASE II TRIAL OF CONCURRENT BEVACIZUMAB AND RE-IRRADIATION VS. BEVACIZUMAB ALONE AS TREATMENT FOR RECURRENT GLIOBLASTOMA Conference

Tsien, Christina, Pugh, Stephanie, Dicker, Adam et al. (2019). NRG ONCOLOGY RTOG 1205: RANDOMIZED PHASE II TRIAL OF CONCURRENT BEVACIZUMAB AND RE-IRRADIATION VS. BEVACIZUMAB ALONE AS TREATMENT FOR RECURRENT GLIOBLASTOMA . NEURO-ONCOLOGY, 21 20-20.

cited authors

  • Tsien, Christina; Pugh, Stephanie; Dicker, Adam; Raizer, Jeffrey; Matuszak, Martha; Lallana, Enrico; Huang, Jiayi; Algan, Ozer; Taylor, Nicholas; Portelance, Lorraine; Villano, John; Hamm, John T; Oh, Kevin S; Ali, Arif N; Kim, Michelle; Lindhorst, Scott; Mehta, Minesh

sustainable development goals

authors

date/time interval

  • November 20, 2019 -

publication date

  • November 1, 2019

published in

keywords

  • Clinical Neurology
  • Life Sciences & Biomedicine
  • Neurosciences & Neurology
  • Oncology
  • Science & Technology

Location

  • AZ, Phoenix

Conference

  • 24th Annual Scientific Meeting and Education Day of the Society-for-Neuro-Oncology (SNO) / 3rd SNO-SCIDOT Joint Conference on Therapeutic Delivery to the CNS

publisher

  • OXFORD UNIV PRESS INC

start page

  • 20

end page

  • 20

volume

  • 21